Total Voting Rights

M. P. Evans Group PLC
02 September 2024
 

M.P. Evans Group PLC

(the "Company")

 

Total voting rights

 

In conformity with Rule 5.6.1 of the FCA's Disclosure and Transparency Rules, the Company notifies the market that as at 31 August 2024, and assuming settlement of shares purchased prior to the date of this announcement pursuant to the Company's share buyback programme (announced on 18 June 2024) the Company's issued share capital comprises 52,824,447 shares of 10p each ("Shares"). All of the Shares have equal voting rights and there are no Shares held in treasury. 

 

This figure of 52,824,447 Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

2 September 2024

 

LEI number: 2138003IBXJUCR4SZG26

 

 

Enquiries:

 

M.P. Evans Group PLC

Tel: +44 (0)1892 516333

Peter Hadsley-Chaplin - Chairman


Matthew Coulson - Chief executive


Luke Shaw - Chief financial officer




Cavendish Capital Markets Limited (Nomad and broker)

Tel: +44 (0)20 7220 0500

Matt Goode, George Lawson, Rory Sale - Corporate finance

Tim Redfern, Harriet Ward - Equity capital markets




Hudson Sandler (Financial PR)

Tel:  +44 (0)20 7796 4133

Charlie Jack, Francis Kerrigan, Francesca Rosser


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings